omega-n-methylarginine has been researched along with magnesium sulfate in 1 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (magnesium sulfate) | Trials (magnesium sulfate) | Recent Studies (post-2010) (magnesium sulfate) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 5,476 | 887 | 1,462 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kajiyama, G; Kato, M; Matsuura, H; Teragawa, H; Yamagata, T | 1 |
1 other study(ies) available for omega-n-methylarginine and magnesium sulfate
| Article | Year |
|---|---|
Magnesium causes nitric oxide independent coronary artery vasodilation in humans.
Topics: Adult; Aged; Blood Flow Velocity; Coronary Circulation; Coronary Vessels; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Humans; Magnesium Sulfate; Male; Middle Aged; Nitric Oxide; omega-N-Methylarginine; Vasodilation; Vasodilator Agents | 2001 |